ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18) - PubMed (original) (raw)
ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18)
M S Diamond et al. J Cell Biol. 1990 Dec.
Abstract
While the leukocyte integrin lymphocyte function-associated antigen (LFA)-1 has been demonstrated to bind intercellular adhesion molecule (ICAM)-1, results with the related Mac-1 molecule have been controversial. We have used multiple cell binding assays, purified Mac-1 and ICAM-1, and cell lines transfected with Mac-1 and ICAM-1 cDNAs to examine the interaction of ICAM-1 with Mac-1. Stimulated human umbilical vein endothelial cells (HUVECs), which express a high surface density of ICAM-1, bind to immunoaffinity-purified Mac-1 adsorbed to artificial substrates in a manner that is inhibited by mAbs to Mac-1 and ICAM-1. Transfected murine L cells or monkey COS cells expressing human ICAM-1 bind to purified Mac-1 in a specific and dose-dependent manner; the attachment to Mac-1 is more temperature sensitive, lower in avidity, and blocked by a different series of ICAM-1 mAbs when compared to LFA-1. In a reciprocal assay, COS cells cotransfected with the alpha and beta chain cDNAs of Mac-1 or LFA-1 attach to immunoaffinity-purified ICAM-1 substrates; this adhesion is blocked by mAbs to ICAM-1 and Mac-1 or LFA-1. Two color fluorescence cell conjugate experiments show that neutrophils stimulated with fMLP bind to HUVEC stimulated with lipopolysaccharide for 24 h in an ICAM-1-, Mac-1-, and LFA-1-dependent fashion. Because cellular and purified Mac-1 interact with cellular and purified ICAM-1, we conclude that ICAM-1 is a counter receptor for Mac-1 and that this receptor pair is responsible, in part, for the adhesion between stimulated neutrophils and stimulated endothelial cells.
Similar articles
- Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers.
Shang XZ, Issekutz AC. Shang XZ, et al. Eur J Immunol. 1998 Jun;28(6):1970-9. doi: 10.1002/(SICI)1521-4141(199806)28:06<1970::AID-IMMU1970>3.0.CO;2-H. Eur J Immunol. 1998. PMID: 9645379 - LFA-1 (CD11a/CD18) triggers hydrogen peroxide production by canine neutrophils.
Lu H, Ballantyne C, Smith CW. Lu H, et al. J Leukoc Biol. 2000 Jul;68(1):73-80. J Leukoc Biol. 2000. PMID: 10914492 - Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: design and mechanism of action.
Zimmerman T, Blanco FJ. Zimmerman T, et al. Curr Pharm Des. 2008;14(22):2128-39. doi: 10.2174/138161208785740225. Curr Pharm Des. 2008. PMID: 18781967 Review. - The pivotal role of the Leu-CAM and ICAM molecules in human leukocyte adhesion.
Gahmberg CG, Nortamo P, Kantor C, Autero M, Kotovuori P, Hemiö L, Salcedo R, Patarroyo M. Gahmberg CG, et al. Cell Differ Dev. 1990 Dec 2;32(3):239-45. doi: 10.1016/0922-3371(90)90036-v. Cell Differ Dev. 1990. PMID: 1983073 Review.
Cited by
- Intercellular Adhesion Molecule 1 (ICAM-1): An Inflammatory Regulator with Potential Implications in Ferroptosis and Parkinson's Disease.
Miller MR, Landis HE, Miller RE, Tizabi Y. Miller MR, et al. Cells. 2024 Sep 15;13(18):1554. doi: 10.3390/cells13181554. Cells. 2024. PMID: 39329738 Free PMC article. Review. - αMI-domain of integrin Mac-1 binds the cytokine pleiotrophin using multiple mechanisms.
Nguyen H, Podolnikova NP, Ugarova TP, Wang X. Nguyen H, et al. Structure. 2024 Aug 8;32(8):1184-1196.e4. doi: 10.1016/j.str.2024.04.013. Epub 2024 May 9. Structure. 2024. PMID: 38729161 - Factors related to serum levels of intercellular adhesion molecule-1 in probable COVID-19 patients in surgical treatment: an observational study.
Oley MH, Oley MC, Langi FLFG, Kepel BJ, Pajan J, Kepel REM, Wagiu AMJ, Kalitouw F, Kalesaran L, Faruk M. Oley MH, et al. Pan Afr Med J. 2023 Dec 27;46:117. doi: 10.11604/pamj.2023.46.117.41690. eCollection 2023. Pan Afr Med J. 2023. PMID: 38465016 Free PMC article. - αMI-domain of Integrin Mac-1 Binds the Cytokine Pleiotrophin Using Multiple Mechanisms.
Nguyen H, Podolnikova NP, Ugarova TP, Wang X. Nguyen H, et al. bioRxiv [Preprint]. 2024 Feb 2:2024.02.01.578455. doi: 10.1101/2024.02.01.578455. bioRxiv. 2024. PMID: 38352421 Free PMC article. Updated. Preprint. - ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer.
Li D, Hemati H, Park Y, Taftaf R, Zhang Y, Liu J, Cristofanilli M, Liu X. Li D, et al. Cancers (Basel). 2023 May 12;15(10):2734. doi: 10.3390/cancers15102734. Cancers (Basel). 2023. PMID: 37345070 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1982 Dec;79(23):7489-93 - PubMed
- J Exp Med. 1982 Oct 1;156(4):1000-9 - PubMed
- J Immunol. 1983 Sep;131(3):1182-8 - PubMed
- J Exp Med. 1983 Dec 1;158(6):1785-1803 - PubMed
- J Clin Invest. 1984 Jan;73(1):153-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous